RCE in Sourcecodester Drug Recommendation System
CVE-2026-108920
A security vulnerability has been detected in SourceCodester Drug Recommendation System 1.0. This affects an unknown function of the file Admin/user_record.php of the component Admin Record Tables. Such manipulation of the argument name/email leads to cross site scripting. The attack can be launched remotely. The exploit has been disclosed publicly and may be used.
Vulnerability class: XSS (Cross-Site Scripting)
Published .
CVSS v3 metric
CVSS v3 base score 4.3 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:L/A:N.
EPSS exploit prediction
No EPSS score from FIRST.org yet. New CVEs usually get one within a few days; no score means no signal yet, not low risk. How EPSS works.
Affected products
- Sourcecodester Drug Recommendation System — versions 1.0
Weakness classification (CWE)
References
- vuldb.com/vuln/416733 (technical-description, vdb-entry)
- vuldb.com/vuln/416733/cti (signature, permissions-required)
- vuldb.com/cve/CVE-2026-108920 (third-party-advisory)
- vuldb.com/submit/970938 (third-party-advisory)
- www.sourcecodester.com/ (product)
Frequently asked questions
- What is CVE-2026-108920?
- CVE-2026-108920 is a medium-severity vulnerability in Sourcecodester Drug Recommendation System, classified under Cross-site Scripting. CVSS score: 4.3/10. Published 2026-10-12.
- How severe is CVE-2026-108920?
- Medium severity. CVSS v3 base score is 4.3 out of 10.